Elanco, Bayer animal health deal clears informal New Zealand review
US-based Elanco Animal Health’s plan to acquire German pharmaceutical company Bayer’s animal-health business in a $7.6 billion deal has cleared a regulatory hurdle in New Zealand after the country’s competition watchdog...To view the full article, register now.
Already a subscriber? Click here to view full article